The coronavirus disease 2019 (COVID-19) drug pipeline is not growing at quite the same
speed as the pandemic. But its rate of expansion is nevertheless cause for pause. In the …

The brutal logic that has divided the world into vaccine haves and havenots is now being
repeated as gamechanging COVID-19 drugs like Pfizer's oral antiviral Paxlovid (nirmatrelvir …

The COVID-19 pandemic has created massive disruptions to clinical trial research across
the world. As in other aspects of life, the virus has severely affected the ability to conduct …

From an evidence-based medicine perspective, drug prescriptions should be based on
credible systematic reviews with metaanalyses of randomised controlled trials that provide …

The treatment landscape for COVID-19 is changing substantially, representing a golden
opportunity for pandemic control, especially in impoverished countries. Until recently, most …

The first wave of coronavirus disease 2019 (COVID-19) pandemic is currently invading the
world, and several countries are now struggling to fight it or trying to delay its start to help …

For the first time in the post-war history of epidemics, there is a reversal of which countries
are most heavily affected by a disease pandemic. By early May, 2020, more than 90% of all …

In response to the global coronavirus disease 2019 (COVID-19) emergency, clinical trial
research assessing the efficacy and safety of clinical candidate interventions to treat COVID …

“To be clear we have one strategic aim: save lives.” So stated a UK Government health
adviser in an email sent to me last weekend. It was an email filled with frustration.“Part of the …

8 Lau C. Coronavirus: Hong Kong hospital workers vow to press on with strike as union
rejects city leader's quarantine plan for travellers from mainland China. South China …